Table 2.
Clinical and genetic characteristics of the study participants.
| Characteristics | Participants (n = 460) |
|---|---|
| BMI (Kg/m2) | 25.71 ± 4.98 |
| Total cholesterol (mg/dL) | 181.41 ± 40.94 |
| High total cholesterol levels n (%) | 351 (76.3) |
| LDL-C (mg/dL) | 117.39 ± 33.52 |
| High LDL-C levels n (%) | 347 (75.4) |
| HDL-C (mg/dL) | 45.53 ± 14.61 |
| Low HDL-C levels n (%) | 270 (58.7) |
| Triglycerides (mg/dL) | 145.96 ± 124.34 |
| High triglycerides levels n (%) | 174 (37.8) |
| SBP (mmHg) | 132.07 ± 15.89 |
| DBP (mmHg) | 67.82 ± 9.12 |
| Hypertension n (%) | 255 (55.4) |
| MAF of rs2569190G in CD14 | 0.41 |
| AA n (%) | 158 (34.3) |
| GA n (%) | 224 (48.7) |
| GG n (%) | 78 (17.0) |
Values are arithmetic mean ± SD for continuous variables. Categorical variables are shown as number (n) and percentages (%). n: sample size. BMI: body mass index, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol, SBP: systolic blood pressure, DBP: diastolic blood pressure, MAF: minor allele frequency, CD14: cluster of differentiation 14.